LRI Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1K Sell
73
-802
-92% -$222K ﹤0.01% 831
2026
Q1
$258K Buy
875
+740
+548% +$220K 0.02% 251
2025
Q4
$36.7K Buy
135
+28
+26% +$7.61K ﹤0.01% 595
2025
Q3
$28.8K Sell
107
-85
-44% -$23.1K ﹤0.01% 643
2025
Q2
$53K Sell
192
-217
-53% -$59K ﹤0.01% 542
2025
Q1
$109K Buy
409
+57
+16% +$14.1K 0.01% 403
2024
Q4
$81.7K Sell
352
-50
-12% -$11.5K 0.01% 447
2024
Q3
$89.9K Sell
402
-123
-23% -$25.5K 0.01% 427
2024
Q2
$103K Buy
525
+493
+1,541% +$102K 0.01% 375
2024
Q1
$6.89K Buy
+32
New +$6.72K ﹤0.01% 569

Other funds holding CME

LRI Investments's CME Position: Q2 2026 in Review

LRI Investments reduced its CME Group (CME) stake by 92% in Q2 2026, selling an estimated $222K and leaving 73 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

LRI Investments first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $258K in Q1 2026. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • LRI Investments held 73 shares of CME Group worth $16.1K as of Q2 2026.
  • LRI Investments sold 802 CME Group shares in Q2 2026, an estimated $222K.
  • CME Group made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #831 holding.
  • LRI Investments first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's CME Group position peaked at $258K in Q1 2026.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.